Anbiser B-ha Hyaluronic Acid Hydrating Essence Toner
NDC Package 84951-005-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Anbiser B-ha Hyaluronic Acid Hydrating Essence Toner is a . Marketed by Qingdao Huinorde Biotechnology Co., Ltd, this product is identified by NDC 84951-005.

Identification & Billing

NDC Package Code
84951-005-01
Package Description
1 BOTTLE in 1 BOX / 100 mL in 1 BOTTLE
Product Code
84951-005
11-Digit Billing Format
84951000501

Clinical Specifications

Proprietary Name
Anbiser B-ha Hyaluronic Acid Hydrating Essence Toner
Dosage Form
-

Regulatory & Marketing

Labeler Name
Qingdao Huinorde Biotechnology Co., Ltd
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
11-18-2024
End Marketing Date
05-30-2025
Listing Expiration
05-30-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84951-005-01 identifies a specific commercial package of 1 bottle in 1 box / 100 ml in 1 bottle of Anbiser B-ha Hyaluronic Acid Hydrating Essence Toner, labeled by Qingdao Huinorde Biotechnology Co., Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Qingdao Huinorde Biotechnology Co., Ltd on November 18, 2024. The current certification is valid through May 30, 2025.

How is this Qingdao Huinorde Biotechnology Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84951000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84951-005-01
11-Digit CMS (5-4-2)
84951-0005-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.